John G.F. Cleland

Name: PROFESSOR JOHN GF CLELAND (GMC: 2331371) Updated:- 20th July 2025 Degrees/Education: 1977 MBChB (Commendation) University of Glasgow, UK 1991 MD University of Glasgow, UK Fellow of the Royal College of Physicians (London) and of Physicians & Surgeons (Glasgow) Fellow of the European Society of Cardiology Fellow of the American College of Cardiology Current Position/Affiliation: 2022 Professor of Cardiology, School of Cardiovascular & Metabolic Health, University of Glasgow. UK. Clinically Active. Tenured. Previous post/Professional Experience: 2016-2022: Director of the Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, Institute of Health and Wellbeing, University of Glasgow, UK. 2013-2022: Professor of Clinical Cardiology, National Heart & Lung Institute, Imperial College, London. 1999-2013: Professor of Cardiology, University of Hull, UK 1994-1998: British Heart Foundation Senior Research Fellow, University of Glasgow. UK 1989-1994: Senior Lecturer (Cardiology). Royal Postgraduate Medical School, Hammersmith Hospital, London. UK Major honours and awards: 2007 Joy Edelman Medal - British Cardiovascular Society 2012 PhD (honorary) – University of Hasselte (Belgium) 2013 JACC CV Imaging – Mentor - Young Author Achievement 2014-24 Thomson-Reuters / Clarivate Highly Cited Researcher 2015 William Stokes Medal of the Irish Cardiac Society 2018 RT Hall Lecture – Australia New Zealand Cardiac Society 2022 Honorary Fellowship of the Heart Failure Society of America 2025 James Mackenzie Medal - British Cardiovascular Society 2022 - Deputy Editor of The European Heart Journal Other Professional Experience: 1999-2006 Founding Editor-in-Chief of European Journal of Heart Failure 2004-2006 President of the British Society for Heart Failure (BSH) 1998-2000 Chair of the Working Group on Heart Failure of the ESC 2016- National Heart Failure Audit Committee for England&Wales 2017-2025 Chair BSH Heart Failure Research Investigators Network Areas of expertise: Bridging the gap between epidemiology and clinical trials in cardiovascular disease, with a special emphasis on pharmaco-epidemiology (especially diuretic therapy), cardiac dysfunction and heart failure. Current interests include the influence of myocardial substrate on therapeutic response, mechanism of recovery of ventricular dysfunction, congestion and inflammation as novel therapeutic targets, iron deficiency, telemonitoring and theranostics. Publication: >1,200 publications cited by PubMed as of 20th July 2025 h-index: Google Scholar 184